The prevalence of neuromyelitis optica in South East Wales

European Journal of Neurology

Volumn 19, Issue 4, 2012, Pages 655-659

  Cossburn, M ^a,b   Tackley, G ^b   Baker, K ^a,b   Ingram, G ^a,b   Burtonwood, M ^b   Malik, G ^b   Pickersgill, T ^b   te Water Naude J ^b   Robertson, N ^a,b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Adult; Epidemiology; Myelitis; Neuromyelitis optica; Optic neuritis; Paediatric

Indexed keywords

AQUAPORIN 4; PROTEIN ANTIBODY;

ADULT; AGED; ARTICLE; CAUCASIAN; CHILD; CLINICAL FEATURE; DATA BASE; DISEASE DURATION; DISEASE REGISTRY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELOOPTIC NEUROPATHY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PATIENT IDENTIFICATION; PATIENT REFERRAL; PATIENT SELECTION; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; AQUAPORIN 4; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROMYELITIS OPTICA; PREVALENCE; WALES; YOUNG ADULT;

EID: 84858339185     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2011.03529.x     Document Type: Article

References (17)

1. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999; 53: 1107-1114.
2. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106-2112.
3. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-1489.
4. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol 2007; 6: 805-815.
5. Cabrera-Gomez JA, Kurtzke JF, Gonzalez-Quevedo A, Lara-Rodríguez R. An epidemiological study of neuromyelitis optica in Cuba. J Neurol 2009; 256: 35-44.
6. Asgari N, Lillevang ST, Skejoe HPB, Falah M, Stenager E, Kyvik KO. A population based Study of neuromyelitis optica in Caucasians. Neurology 2011; 76: 1589-1595.
7. Swingler RJ, Compston DA. The prevalence of multiple sclerosis in south east Wales. J Neurol Neurosurg Psychiatry 1988; 51: 1520-1524.
8. Hirst C, Ingram G, Pickersgill T, Swingler R, Compston DA, Robertson NP. Increasing prevalence and incidence of multiple sclerosis in South East Wales. J Neurol Neurosurg Psychiatry 2009; 80: 386-391.
9. Hennessey A, Swingler R, Compston A. The incidence and mortality of multiple sclerosis in South-East Wales. J Neurol Neurosurg Psychiatry 1989; 52: 1085-1089.
10. Ingram G, Colley E, Ben-Shlomo Y, et al. Validity of patient-derived disability and clinical data in multiple sclerosis. Mult Scler 2010; 16: 472-479.
11. United Kingdom Census 2001. Available from: (accessed 20/04/2011).
12. Muzaimi MB, Thomas J, Palmer-Smith S, et al. Population based study of late onset cerebellar ataxia in south east Wales. J Neurol Neurosurg Psychiatry 2004; 75: 1129-1134.
13. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.
14. Roxburgh RH, Seaman SR, Masterman T, et al. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 2005; 64: 1144-1151.
15. Barkhof F, Rocca M, Francis G, et al. Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta1a. Ann Neurol 2003; 53: 718-724.
16. Cabre P, Heinzlef O, Merle H, et al. MS and neuromyelitis optica in Martinique (French West Indies). Neurology 2001; 56: 507-514.
17. Kuroiwa Y, Igata A, Itahara K, Koshijima S, Tsubaki T. Nationwide survey of multiple sclerosis in Japan. Clinical analysis of 1, 084 cases. Neurology 1975; 2: 845-851.